Sunnbrook Odette Cancer Centre
Toronto, Ontario, M4N 3M5, Canada
NCT Number: NCT01881022
Diagnosis and treatment of breast cancer often leads to lower levels of sexual desire, decreased sexual arousal, painful intercourse, and difficulties achieving orgasm, and thus adversely impacts sexual functioning and intimacy. Despite the overwhelming evidence that many couples experience sexual distress following breast cancer, very few interventions have been designed exclusively to address these concerns. The purpose of this study is to develop and evaluate an online psychosexual program geared to the unique needs of couples experiencing sexual distress after breast cancer. This study will utilize a web-based approach, allowing couples to participate in the program from the privacy and comfort of their homes, and providing a resource to couples who may not otherwise be able to readily access support. Accordingly, this project has the potential for widespread positive impact for couples affected by breast cancer.
Looking for future studies?
Notify MeUp to 80 year
All sexes
Interventional
Not applicable
Toronto, Ontario, M4N 3M5, Canada
Many couples experience sexual problems following breast cancer treatment, and difficulties with intimacy and sexuality tend to extend past the 1 year post-treatment point. Given that resources available for couples who experience sexual distress after breast cancer are virtually non-existent, there is a need to develop and empirically evaluate psychosexual interventions for breast cancer patients and their partners.
The purpose of this study is to evaluate the feasibility, process, and outcomes of an online, couples-based intervention designed to address sexual problems encountered by many couples facing breast cancer. The intervention will take place in the form of six E-therapy sessions delivered via secure, encrypted videoconferencing software commonly used by health care providers practicing telemedicine. Each session will be supplemented by psychoeducational materials (i.e. reading and/or video) available through a privately accessed homepage for the study.
Thirty couples will participate in the study, and will be be randomized to either the treatment condition or the wait-list control condition. Participants assigned to the wait-list will have the option of receiving the online program once they have completed their commitment to the study (approximately 5 months later). In addition to completing standardized questionnaires, couples will participate in pre- and post-treatment interviews, which will be analyzed thematically in order to improve the intervention and its delivery.
The proposed project builds upon existing research pertaining to the sexual health implications of female cancer survivorship, and will fill a gap both in the literature and support available to breast cancer survivors experiencing sexual distress. Given that sexual distress is such a crucial concern for women with breast cancer, and that the majority of couples experiencing sexual difficulties may not receive adequate support in this regard, the goal of the proposed project will be the creation of an accessible, cost-effective, empirically validated tool that could help improve the quality of life of couples affected by breast cancer.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-Patient has received a diagnosis within the last 5 years of invasive breast carcinoma (non- metastatic), or ductal carcinoma in-situ
chemotherapy, radiation, tamoxifen)
Exclusion criteria
Couples will complete six weekly psychosexual counselling sessions. Each session will focus on areas relevant to sex therapy and sexual dysfunction in couples facing breast cancer (e.g. education, communication, body imagery, sensate focusing, and problem solving). Sessions will be one hour in length (Note: Session 1 will be 1.5 hours), during which couples will meet with a facilitator via videoconferencing.
Time frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and 3 month follow-up
The SFQ assesses couples' sexual satisfaction and functioning. The SFQ will be used to assess change in couples' level of sexual functioning.
Time frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and 3 month follow-up
The RDAS assesses couple's level of relationship satisfaction.
Time frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and 3 month follow-up
The Maudsley Marital Questionnaire assesses martial quality and happiness.
Time frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up
The POMS-SF assesses overall psychological adjustment.
Time frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up
This measure assesses psychological adjustment, specifically with respect to depressive symptoms.
Time frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up
This measure assesses psychological adjustment, specifically with respect to anxiety
Time frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up
The BCPT measures commonly reported physical and psychological symptoms associated with breast cancer and associated treatments.
Time frame: pre-treatment (0 weeks), immediate post-treatment (6 weeks), and three months follow-up
The SSC measures partners' perceived support of their female partners
Time frame: Pre-treatment (0 weeks)
The Program Expectancy Questionnaire will assess participants' expectations for the intervention, including the degree to which they believe the intervention will be effective.
Sunnybrook Health Sciences Centre
Other
An Evaluation of an Internet-based, Psychosexual Intervention for Couples Following Treatment for Breast Cancer: A Phase I Trial
Acronym: IPSIC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00062400
Behavior, Breast Cancer
Brussels, Belgium
View Trial DetailsNCT01573442
Arthralgia, Breast Cancer
Anchorage, Alaska, United States
View Trial DetailsNCT04221607
Breast Cancer, Breast Diseases
Providence, Rhode Island, United States
View Trial DetailsNCT02667626
Breast Cancer, Breast Diseases
La Jolla, California, United States
View Trial Details